GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,412,000 | +119.9% | 13,509 | +141.9% | 0.01% | +100.0% |
| Q3 2019 | $642,000 | +24.9% | 5,584 | +87.4% | 0.01% | +25.0% |
| Q2 2019 | $514,000 | +4.3% | 2,979 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $493,000 | +41.7% | 2,922 | -18.4% | 0.00% | +33.3% |
| Q4 2018 | $348,000 | -48.6% | 3,579 | -8.7% | 0.00% | -57.1% |
| Q3 2018 | $677,000 | +146.2% | 3,919 | +98.7% | 0.01% | +75.0% |
| Q2 2018 | $275,000 | +70.8% | 1,972 | +38.3% | 0.00% | +100.0% |
| Q1 2018 | $161,000 | -13.9% | 1,426 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $187,000 | +24.7% | 1,417 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $150,000 | 0.0% | 1,484 | -1.1% | 0.00% | -33.3% |
| Q2 2017 | $150,000 | -8.0% | 1,500 | +10.7% | 0.00% | 0.0% |
| Q1 2017 | $163,000 | +25.4% | 1,355 | +16.9% | 0.00% | 0.0% |
| Q4 2016 | $130,000 | +3.2% | 1,159 | +22.1% | 0.00% | 0.0% |
| Q3 2016 | $126,000 | +137.7% | 949 | +58.2% | 0.00% | +200.0% |
| Q2 2016 | $53,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |